From a clinical investigation standpoint, the development of novel treatments requires a rigorous and detailed approach. We are witnessing a pivotal shift from traditional models, embracing personalized medicine and increasingly complex methodologies. Cutting-edge biomarker discovery, coupled with sophisticated imaging techniques, is allowing for a